Synthesis and Docking Study of Novel 4-Thiazolidinone Derivatives as Anti-Gram-positive and Anti-H. pylori Agents
-
Published:2019-01-11
Issue:3
Volume:19
Page:239-249
-
ISSN:1389-5575
-
Container-title:Mini-Reviews in Medicinal Chemistry
-
language:en
-
Short-container-title:MRMC
Author:
Khomami Armin1, Rahimi Mohammadamin1, Tabei Arash1, Saniee Parastoo2, Mahboubi Arash3, Foroumadi Alireza4, Koopaei Nasrin Nassiri1, Almasirad Ali1
Affiliation:
1. Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran 2. Department of Microbiology and Microbial Biotechnology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University G.C, Tehran, Iran 3. Food Safety Research Center, Department of Pharmaceutics, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran 4. Department of Medicinal Chemistry, Faculty of Pharmacy and The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran
Abstract
Background:
Bacterial resistance to the available antibiotics is a life threatening issue and
researchers are trying to find new drugs to overcome this problem. Amongst the different structural
classes, thiazolidinone-4-one, as a new effective pharmacophore against various bacteria, has been introduced.
Objective:
A new series of 2-(5-(5-nitrothiophene-2-yl)-1,3,4-thiadiazole-2-ylimino)-5-arylidenethiazolidin-
4-one derivatives were designed and synthesized as new antibacterial agents.
Method: Target compounds were synthesized during 5 steps and their in vitro antibacterial and anti-H.
pylori activities were evaluated. The interaction of the most active derivatives with the probable targets
was assessed by Auto Dock 4.2 Program.
Results:
The results showed that the most potent compounds, 18, 22 and 23, displayed antibacterial activity
versus S.aureus, S.epidermidis, B.cereus and B.subtilis (MIC, 1.56-12.5 µg/mL) and none of the
derivatives were active on tested Gram-negative bacteria. Compound 12 in all considered doses and
compounds 10, and 27 had strong anti-H. pylori activity (inhibition zone >20 mm) in 25 μg disc.
Docking studies determined suitable interactions and affinity of potent compounds with bacterial MUR
B and H. pylori urease enzymes.
Conclusion:
According to the results most of the derivatives are effective anti-bacterial agents and
docking evaluation confirmed their possible mechanisms of actions as MURB and Urease inhibitors.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmacology,General Medicine
Reference26 articles.
1. World Health Organization, . http://www.who.int/mediacentre/factsheets/fs310/en (October)., The top ten causes of death., , 2. Leal JR, Conly J, Henderson EA, Manns BJ. Antimicrob Resist Infect Control, How externalities impact an evaluation of strategies to prevent antimicrobial resistance in health care organizations.,, 2017, 6,, 53-, 3. Icgen B. Bull Environ Contam Toxicol, VanA-Type MRSA (VRSA) Emerged in Surface Waters.,, 2016, 97,, 359-366, 4. Saka A, Yagi K, Nimura S. Gastric Cancer, Endoscopic and histological features of gastric cancers after successful Helicobacter pylori eradication therapy.,, 2016, 19,, 524-530, 5. Whitener CJ, Park SY, Browne FA, Parent LJ, Julian K, Bozdogan B, Appelbaum PC, Chaitram J, Weigel LM, Jernigan J. Clin Infect Dis, Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure.,, 2004, 38,, 1049-1055,
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Synthesis and Identification of New N,N-Disubstituted Thiourea, and Thiazolidinone Scaffolds Based on Quinolone Moiety as Urease Inhibitor;Molecules;2022-10-21 2. Synthesis of new 2-(5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-ylimino)thiazolidin-4-one derivatives as anti-MRSA and anti-H. pylori agents;BMC Chemistry;2022-05-27 3. 1,3,4-thiadiazole: A Privileged Scaffold for Drug Design and Development;Current Topics in Medicinal Chemistry;2021-11 4. Substituted 6,7-dimethoxy-5-oxo-2,3,5,9b-tetrahydrothiazolo[2,3-a]isoindole- 3-1,1-dioxide Derivatives with Antimicrobial Activity and Docking Assisted Prediction of the Mechanism of their Antibacterial and Antifungal Properties;Current Topics in Medicinal Chemistry;2020-11-20
|
|